Hotspot oncogenic drivers, truncating loss-of-function mutations and CNAs were identified in members of critical breast cancer pathways, including P53, receptor tyrosine kinase (RTK), PI3K and MAPK signaling, as well as cell cycle, transcriptional and epigenetic regulators and were highly conserved in PDXs (Fig. 2c). The gene discussed is TP53; the disease is breast carcinoma.